Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 70.25

+0.1%

Nov 6 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (1789)	5/22/2007 3:10:54 PM
From: Jibacoa	Read Replies (2) of 3722

AGIX Is up 17.4%, but still has some way to go before it can start closing some of its March 19 DG. bigcharts.marketwatch.com March 19 was when it announced that its ARISE PIII of AGI-1067, did not show a difference from placebo in its primary endpoint; however, it did achieve a number of other important predefined endpoints. <g> Those endpoints included a reduction in the composite of "hard" atherosclerotic clinical endpoints, composed of cardiovascular death, myocardial infarction and stroke, as well as an improvement in several diabetes parameters, including glycemic control. bigcharts.marketwatch.com However, its 1stQ results showed 175% improvement on revenues & the loss was cut to $0.32 vs. $0.49/shr in 2006. The EL for 2007 is around $1.05/shr vs. $1.71 in 2006 & $2.19 in 2005 & fo 2008 the EL is still lower around $0.74, so it seems AGIX has a good chance of getting back to the $4 to $5 level for a good % gain, albeit it may not get to close the March DG for a while & less likely it will meet its "target" of $19 as per Yahoo Finance.<g> At any rate, the R/R doesn't look bad at present levels. bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next